Recent News

• 06.02.2025 - Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
• 05.08.2025 - Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
• 05.01.2025 - Sutro Biopharma to Participate in Upcoming Investor Conferences
• 04.28.2025 - Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025

Recent Filings

• 05.30.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 8-K Current report
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.25.2025 - DEF 14A Other definitive proxy statements